Fairvalue-Calculator Fairvalue-Calculator
EN DE

Acrux Limited (ARUXF) Fair Value & Analysis

Healthcare · US · Market cap $8.8M

Price$0.0169
Fair Value$0.0100
Upside-40.8%
Quality95/100
Evidence: Low

Fair value as of: Jun 24, 2026

Analysis

Acrux Limited (ARUXF) currently trades at $0.0169, while our model-based Fair Value estimate is $0.0100 — implying the stock looks roughly 40.8% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Acrux Limited, together with its subsidiaries, develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally. The company provides estradiol transdermal sprays to women for the treatment of flushes associated with menopause under the Evamist and Lenzetto brand names; Dapsone 5% and Dapsone 7.5%, which are gels for the treatment of acne vulgaris; and Lidocaine and Prilocaine Cream USP, a topical anesthetic cream. It is also involved in the development of Efinaconazole, a topical solution used to treat fungal infections of toenails; Nitroglycerin 0.4%, an ointment for the treatment of pain associated with chronic anal fissure; and Acyclovir 5%, a cream for the treatment of cold sores. The company was incorporated in 1998 and is based in West Melbourne, Australia.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -27% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is Acrux Limited (ARUXF) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.0100 versus a price of $0.0169 — about −41% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ARUXF?
Our 21-model fair value for Acrux Limited is $0.0100 (as of Jun 24, 2026), built from audited fundamentals. The current price is $0.0169.
What is the quality score of ARUXF?
Acrux Limited has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.